Dose-response modeling in high-throughput cancer drug screenings: An end-to-end approach
Biostatistics (Oxford, England), 2020.
Personalized cancer treatments based on the molecular profile of a patient's tumor are an emerging and exciting class of treatments in oncology. As genomic tumor profiling is becoming more common, targeted treatments for specific molecular alterations are gaining traction. To discover new potential therapeutics that may apply to broad cla...More
PPT (Upload PPT)